The density of PD-1+FOXP3+CD4+ cells and PD-L1–expressing cells was higher in group 1 than in group 2, suggesting that immunosuppressive Tregs and PD-L1 expression by the tumor may impede long-term responses to T-DXd. The gene discussed is CD4; the disease is neoplasm.